| Prograf® (tacrolimus capsule) |
|
|
Prograf® (tacrolimus) injection |
|
|
| NDC Number |
Product Number |
Desc
ription |
Strength |
Concen
tration |
Size |
Unit of Sale |
Closure |
| 0469-0607-73 |
060773 |
Prograf Capsules |
0.5 mg |
N/A |
100 ct bottle |
10 |
N/A |
| 0469-0617-73 |
061773 |
Prograf Capsules |
1 mg |
N/A |
100 ct bottle |
10 |
N/A |
| 0469-0657-73 |
065773 |
Prograf Capsules |
5 mg |
N/A |
100 ct bottle |
10 |
N/A |
| 0469-0617-11 |
061711 |
Prograf Capsules |
1 mg |
N/A |
10 x 10 unit dose blister pak |
1 |
N/A |
| 0469-0657-11 |
065711 |
Prograf Capsules |
5 mg |
N/A |
10 x 10 unit dose blister pak |
1 |
N/A |
|
|
| Each capsule contains: |
| Tacrolimus, Anhydrous |
| Inactive Ingredients |
| Lactose |
| Hydroxypropyl Methylcellulose |
| Croscarmellose Sodium |
| Magnesium Stearate |
| Prograf capsules are not filled to maximum capsule capacity. Capsule contains labeled amount. |
|
|
Prograf® (tacrolimus) injection |
| NDC Number |
Product Number |
Desc
ription |
Strength |
Concen
tration |
Size |
Unit of Sale |
Closure |
| 0469-3016-01 |
301601 |
Ampule |
5 mg |
5 mg/mL |
1 mL |
10 |
N/A |
|
|
| Each mL contains: |
| Tacrolimus, Anhydrous |
5 mg |
| Polyoxyl 60 Hydrogenated Castor Oil (HCO-60) |
200 mg |
| Dehydrated Alcohol, USP |
80% v/v |
| Preservative Free |
| Prograf capsules are not filled to maximum capsule capacity. Capsule contains labeled amou
nt. |
|
|
Prograf® is a registered trademark of Astellas Pharma Inc. |
